Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending June 2, 2005. The report details corporate actions taken following shareholder authority granted at the Annual General Meeting on May 25, 2005, specifically regarding share buybacks and updates to directors' interests.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. It focuses exclusively on capital structure changes and share ownership data.
- Treasury Shares Held: 93,733,000 (as of June 1, 2005).
- Shares in Issue (excluding Treasury): 5,848,991,837 (as of June 1, 2005).
- Share Buyback Prices:
- May 27, 2005: 1,359.7143 pence per share.
- May 31, 2005: 1,358.005 pence per share.
- June 1, 2005: 1,364.9265 pence per share.
- US Retirement Savings Plan ADRs: Decreased from 18,320,808 to 18,301,017 at an average price of $49.49.
Material Changes
The primary material change is the reduction of outstanding shares through three separate repurchase transactions totaling 1,500,000 shares between May 27 and June 1, 2005. Additionally, the GlaxoSmithKline US Retirement Savings Plan saw a reduction in ADR holdings due to fund movements, and the GSK Trust transferred 4,079 shares to participants in the SmithKline Beecham Employee Share Option Plan 1991.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future performance. It explicitly states that the announcements do not constitute an offer or solicitation to purchase securities. No specific risks or contingencies are detailed beyond standard regulatory disclosures regarding the nature of the share transactions.
Investor Verification Checklist
- Verify the total number of shares held in Treasury (93,733,000) against the company's latest capitalization table.
- Confirm the weighted average price of the recent buybacks against market trading data for late May and early June 2005.
- Review the impact of the 1,500,000 share reduction on earnings per share (EPS) in subsequent quarterly reports.
- Check the status of the SmithKline Beecham Employee Share Option Plan 1991 regarding the 4,079 shares transferred.